Iodinated granulocyte-macrophage colony-stimulating factor (GM-CSF) was used t o document the specific binding of GM-CSF t o all acute myeloblastic leukemia (AML) samples examined in the present study. There was some heterogeneity in the number of GM-CSF binding sites per cell. To determine whether the low level of binding t o some patient samples may be attributed t o receptor occupancy by an endogenous source of GM-CSF, we devised an acid wash procedure that could remove surface-bound GM-CSF without affecting receptor properties. We thus document that GM-CSF specific binding t o AML blasts before or after acid wash was the same, indicating that the observed heterogeneity in binding is not the result of receptor occupancy by an endogeneous source of GM-CSF. Saturation analyses REVIOUS STUDIES on the in vitro proliferation of P leukemic cells from patients with acute myeloblastic leukemia (AML) have shown that colony formation by clonogenic blasts is, in most cases, optimal on addition of exogenous colony-stimulating factors.' Granulocyte-macrophage colony-stimulating factor (GM-CSF), either by itself or in association with other cytokines, can induce proliferation of clonogenic blasts with, however, wide patient-topatient variations.*-'
P leukemic cells from patients with acute myeloblastic leukemia (AML) have shown that colony formation by clonogenic blasts is, in most cases, optimal on addition of exogenous colony-stimulating factors.' Granulocyte-macrophage colony-stimulating factor (GM-CSF), either by itself or in association with other cytokines, can induce proliferation of clonogenic blasts with, however, wide patient-topatient variations.*- ' The first step in the proliferative action of GM-CSF on normal and leukemic hematopoietic progenitors as well as in the functional priming of neutrophil for activation by formylmethyl-leucyl-phenylalanine (fMLP) is mediated by ligand binding to specific membrane
In the murine system, granulomonopoietic cells appear to express two distinct types of GM-CSF membrane-binding proteins with high and low affinities, the dissociation constants (kd) being 20 to 50 pmol/L and 800 to 1,200 pmol/L Only the high-affinity binding site appears to have a physiologic importance in the proliferative effect of GM-CSF on murine hematopoietic cells. Indeed, the median effective concentration (EC,,) required to produce half-maximal stimulation is always in the range of the kd of the high-affinity receptor." In the human hematopoietic system, a highaffinity binding protein was initially identified by several groups of More recent studies also suggest the presence of a low-affinity binding site on leukemic cells as well as on nonhematopoietic tissue^.'^-'^ The objectives of the present study were threefold. The first was to address the question of whether the heterogeneity in GM-CSF binding to AML blasts could be the result of receptor occupancy by an endogenous source of GM-CSF, as AML blasts have been reported to secrete GM-CSF.'6.'7 The second was to determine whether AML blasts express one or two classes of GM-CSF binding sites. The third objective is to approach the question of the biological significance of GM-CSF receptor expression by AML blasts. To address these issues, we improved the acid wash procedure, widely used to remove surface-bound ligands, to remove GM-CSF without denaturing GM-CSF receptors. Using the technique, we showed that heterogeneity in GM-CSF binding to AML blasts is not the result of receptor occupancy. In addition, we improved the binding conditions by adjusting the time and temperature of incubation and the number of cells per point. We were therefore able to document GM-CSF specific binding to all AML samples surveyed. Finally, our results suggest the presence of a high-affinity and a low-affinity GM-CSF binding site on AML blasts and two established cell lines. Clonogenic assays performed in parallel with binding studies indicate that the kd of the highaffinity binding site is in the same range as the concentrations of GM-CSF required for biological activity.
MATERIALS AND METHODS
AML blasts were obtained by separating peripheral blood (PB) cells on a Ficoll-Hypaque gradient (1.077, Pharmacia, Uppsala, Sweden). All samples were from adult patients; French-American-British (FAB) classification and percentage of blasts in the PB are shown in Table 1 . Cell morphology after Ficoll-Hypaque separation was determined on Giemsa-stained cytosmears. Samples were selected for high blast counts. Binding and culture studies were performed on either fresh or frozen cells. The cells were cryopreserved in 90% fetal calf serum (FCS, GIBCO, Grand Island, NY) and 10% dimethylsulfoxide (DMSO) and stored in liquid nitrogen until use. A programmed freezing rate of 1°C/min allows a cell viability greater than 90% on thawing as determined by Trypan blue exclusion. The KG-1 myelo-60 ONETTO-POTHIER ET AL The effect of recombinant GM-CSF (rGM-CSF) (5 to 750 pmol/L) on blast colony formation was determined by plating lo4 AML blasts or lo3 KG-I cells in 96-microwell dishes (Linbro, Flow Laboratories, McLean, VA) in 100 pL IMDM viscosified with methylcellulose (Fluka, Switzerland, 1% wt/vol) and supplemented with 10% FCS. Cultures stimulated with an optimal concentration of conditioned medium from the cell line 5637 were included as standard positive controls. After 5 to 7 days, colonies containing more than 20 cells were counted.' EC,p of GM-CSF titration curves were estimated by computer modeling with the program Allfit, based on a nonlinear least-square curve-fitting routine.I9
Radioiodination of GM-CSF and determination of the biologic activity. GM-CSF was iodinated by an adaptation of the iodobeads technique described previously2'; 1.5 to 3.5 pg rGM-CSF was iodinated with 1 or 2 mCi of I2,I-Na (IMS 300 529.1 MBq, Amersham, Arlington Heights, IL) with two chloramine-T-upled iodobeads added (Pierce Chemical, Rockford, IL) in 100 pL potassium phosphate buffer (100 mmol/L, pH 7) containing 1 mmol/L Chaps (Sigma, St Louis, MO) for 30 minutes at 4OC. Labeled GM-CSF was separated from free iodine by rapid gel filtration on a IO-mL column of Sephadex G-25 (Pharmacia) equilibrated with 1 mmol/L Chaps/lO mmol/L HEPES. All samples were further purified by a second gel-filtration step. Free iodine was less than 6%, as determined by precipitation with trichloroacetic acid. Radiolabeled GM-CSF was stored in small aliquots at 4OC in 1 mmol/L Chaps/lO mmol/L HEPES supplemented 1% bovine serum albumin (BSA) and was stable for at least 4 weeks.
Conservation of the biologic activity after iodination was determined by comparative titration curves of labeled and cold GM-CSF performed on AML blasts as well as on KG-I cells. Iodination at room temperature or for a longer incubation time resulted in some loss of biologic activity, whereas the conditions already described did not affect the dose-response curves in culture (data not shown).
GM-CSF iodinated by the Bolton-Hunter technique was obtained
Clonogenic assay.
from Du Pont (Wilmington, DE) and used where indicated. The specific activity of the different batches for the Bolton-Hunter iodinated protein was in the range of 3 to 6 x IO', cpm/mmol. To determine the specific activity of our labeled GM-CSF, we quantitated protein recovery after iodination by an adaptation of the silver stain technique described by Kristal." Ten to 100 ng cold GM-CSF in 50 pL of 10 mmol/L HEPES/l mmol/L Chaps was added to 20 pL freshly prepared solution of 0.5% SDS (enzyme immunoassay, EIA purity, BioRad). After dilution to 1 mL with water distilled three times (Milli Q system), 20 pL 2.5% gluteraldehyde (Baker Chemical, Phillipsburg, NJ) was added to each sample, and the tubes were vortexed for 2 seconds. The colorimetric reaction with silver nitrate was initiated by addition of 200 pL ammoniacal silver solution" and allowed to proceed for 30 minutes at room temperature. The reaction was stopped by adding 40 pL sodium thiosulfate (30 mg/mL, Baker) to each tube. The absorbance at 420 nm was measured against an appropriate blank containing no protein but all the other compounds.
The standard curves were established with solutions containing known concentrations of GM-CSF. Use of cold GM-CSF to establish the standard curve is essential since the intensities of the silver colorimetric reaction are different for albumin and GM-CSF (data not shown). In our studies, the detection limit of the assay was on the order of 5 to 10 ng GM-CSF (Fig 1) .
Our labeling technique resulted in a reproducible incorporation of iodine into GM-CSF, and the range of the specific activities for the different batches of GM-CSF was 0.4 to 2 x lo', cpm/mmol. The maximum binding capacity was determined with KG-I, HL-60, and OCI-AMLl cells, according to the procedure of Calvo et aL2'
Binding was performed at 23OC for 90 minutes, unless otherwise stated. Saturation curves were established by incubating 1 to 10 x 1O'cells with varying amounts of "'1-GM-CSF (5 to 2,500 pmol/L) in a total volume of 400 pL radioreceptor buffer (bicarbonate-free IMDM supplemented with 1% BSA). When appropriate, a 150-fold excess of cold GM-CSF was added to evaluate the nonspecific binding. Separation between bound and free GM-CSF was achieved by centrifugation through an oil gradient (84% silicone, Edwards, Ontario, Canada; 16% paraffin, Fisher, Fair Lawn, NJ) at 4°C (9,000 x g, 120 second^).'^ The bottom of the tube was cut, and the radioactivity bound to the cell pellet was counted.
Specific signals on KG-1 cells was linear, with cell number between 2 and 16 x lo6 cells (data not shown). Binding specificity was established by the fact that interleukin-la (IL-la), TNFa, IL-6, or transferrin (200-fold excess) was unable to induce a Determination of the specific activity.
Bindingstudies.
For personal use only. on October 3, 2017. by guest www.bloodjournal.org From Results of the saturation experiments were analyzed with a computer modeling method using a nonlinear least-squares regression model.24 Saturation curves were analyzed according to a model of one class or two classes of binding sites. The more complex model of two classes of binding sites was retained when it significantly improved the goodness of fit.25
Acid wash was performed either after binding to establish the acid lability of surface-bound GM-CSF or before binding to remove an eventual source of endogenous GM-CSF.
When acid wash was performed after binding, the excess of '"1-GM-CSF was first removed by centrifugation through a 1-mL layer of FCS. The cell pellet was resuspended for 1 minute on ice in IMDM acidified with acetic acid to pH 4.0. After centrifugation (1 5 seconds, 9,000 x g), the radioactivity associated with the cell pellet was counted. Where indicated, cells were exposed to acid medium before binding, under the same conditions but with one exception in that the incubation mixture was rapidly diluted with 100-fold excess of cold IMDM before centrifugation (10 minutes, 300 x g). Neutralization of the acid medium by rapid dilution is essential to conserve membrane integrity for subesquent binding studies.
Acid wash procedure.
RESULTS

Binding of GM-CSF at different temperatures.
To establish the optimal conditions to perform saturation analyses of "'1-GM-CSF with human AML blasts, the kinetics of GM-CSF binding to KG-1 cells was studied a t different temperatures. As shown in Fig 2, at 4°C (under conditions in which receptor internalization does not occur), the kinetics of association was very slow and equilibrium was not reached before 12 to 18 hours. Furthermore, the specific signal observed a t 4°C was consistently 60% lower than that obtained at room temperature. At 37OC, the kinetics of binding was rapid and the maximum was reached within 20 to 40 minutes. Binding decreased thereafter, suggesting a transient steady state. Furthermore, the level of maximum specific binding was always inferior to the signal observed a t 23OC (range 85% to 95% in four experiments). At 23OC, association of GM-CSF with KG-1 cells was rapid and reached a stable equilibrium after 60 minutes. We therefore chose to study GM-CSF binding at 23OC with an incubation time of 90 minutes.
Our first objective was to establish an acid wash procedure that could remove surface-bound GM-CSF without altering receptor configuration. Binding was performed a t 8°C for 4 hours to minimize receptor internalization. After binding, KG-1 cells were exposed to medium acidified with acetic acid to pH 3,4, and 5 and for different times (1 or 2 minutes). Thus, we found that an acid wash at pH 4 for 1 minute on ice was sufficient to remove more than 80% of specifically bound GM-CSF (Table 2 ).
In addition, because it was important to verify that this acid wash procedure did not alter GM-CSF binding characEffect of acid wash on GM-CSF binding. 3 and 4) . Nevertheless, the level of binding was variable. At 200 pmol/L 1Z51-GM-CSF, the average number of GM-CSF molecules bound per cell ranged from 38 to 448 (Table 3) . Binding studies performed with GM-CSF iodinated by the iodobeads technique or the Bolton-Hunter reagent technique gave comparable results. To determine whether the low level of binding observed with some patient samples could be related to receptor occupancy by an endogenous source of GM-CSF, cells were subjected to acid wash before binding. As shown in Table 3 , the acid wash did not modify the specific binding of GM-CSF to AML blasts.
Characteristics of GM-CSF receptors of AML blasts and leukemic cell lines. Saturation experiments were performed on I O AML samples for which a sufficient number of cells was available (>lo8 cells). Saturation curves were
Expression of GM-CSF receptors on AML blasts. 
GM-CSF specific binding was determined at 200 pmol/L '251-GM-CSF.
Numbers of molecules of GM-CSF bound per cell without acid treatment are the mean k SD of two or three determinations. Data were corrected for nonspecific binding and maximum binding capacity. Numbers in parentheses were determined separately, using GM-CSF iodinated by the Bolton-Hunter reagent. Where indicated, cells were subjected to acid treatment before binding, as described in the Materials and Methods section.
established with concentrations of radioligand that covered nearly three logarithmic decades ( 5 to 2,500 pmol/L), depending on the availability of the cells, or otherwise with concentrations that covered two decades (5 to 300 pmol/L (Fig 4) . Nonsaturable binding was observed with the wider range of radioligand. A good fit with experimental data was obtained when statistical analyses were performed assuming two classes of binding site with high and low affinities. The kd of the high-affinity binding site was relatively constant in the 10 AML samples studied and was always less than 23 pmol/L (Table 4) with the exception of AML samples 10 and 12, probably owing to contamination by monocytes ( 12% and 5%, respectively) and AML 13, probably owing to uncertainties caused by the weak signal. In contrast, variations in the average number of receptors per cell were wider, ranging from 10 to 400 (samples 10 and 12 excluded). The kd of the low-affinity binding site was in the range of 1 to 10 nmol/L, with a much higher number of sites per cell (200 to 3,000) ( Table 5 ). Errors in the estimation of the binding parameters of the low-affinity binding site were relatively higher because of limitations in the number of cells available to allow coverage of a wider range of concentrations of 1251-GM-CSF. Saturation curves established with the lower range of radioligand allowed only the estimation of the kd and maximum binding (Bmax) of the high-affinity receptor. In most cases, SE in the estimation of these parameters by curve-fittingI2 was less than 50%. Higher SE was observed with samples that exhibited low levels of binding, probably because experimental data are less accurate when the specific signal is weak. Furthermore, the characteristics of GM-CSF binding were comparable using radioligands iodinated by two different techniques ( Table 4) .
The characteristics of GM-CSF binding to the leukemic cell lines KG-I and IRCM-8 were also studied (Figs 4 and 5 , Table 4 ). Statistical analyses of saturation curves were compatible with the presence of two classes of binding sites, with a kd of 30 pmol/L and 1 to 10 nmol/L, respectively. However, expression of the low-affinity binding site in AML The average number of receptors per cell (R) and the dissociation constant (kd) were obtained by analysis of saturation curves with the program Scafit. In the case of AML 9 and 18, the number of cells was insufficient to perform saturation analyses; values for these two samples were the number of molecules bound at 135 pmol/L. 'Where indicated, saturation curves were established with GM-CSF iodinated by the Bolton-Hunter reagent. GM-CSF binding to KG-1 cells was studied before (1A) and after exposure to acid medium (le); before (2A) and after freezing (28). The median effective concentration (EC, , )
was estimated from analysis of GM-CSF titration curves in culture with the program Allfit, as shown in Fig 6. blasts appeared to be more important than that of the high-affinity binding site, whereas the two were present in comparable numbers in KG-1 and IRCM-8 cells. Because most saturation curves on AML blasts were performed with frozen cells, it was important to determine whether the process of freezing and thawing might have caused a partial denaturation of GM-CSF receptor, hence creating a greater number of low-affinity binding sites. Half of the KG-1 cells used for saturation analysis (Fig 5A) were frozen in dimethylsulfoxide (DMSO) and subsequently thawed for comparative binding studies. Saturation curves performed on cells immediately after thawing revealed no significant difference from cells that had been maintained in culture, suggesting that the binding properties of GM-CSF receptor were not altered by freezing (Fig 5B) . That the cell line IRCM-8 was established from long-term culture of AML-8 cells is of interest. Comparison of saturation curves clearly indicate a significantly greater number of high-affinity binding sites on IRCM-8 cells, whereas the numbers of low-affinity binding sites were comparable between the two cell types (Fig 4) .
Comparison between the proliferative response to GM-CSF and GM-CSF receptor expression. Most but not all patient cells can respond to GM-CSF. Thus, colony formation was observed with GM-CSF in 11 of the 13 AML samples studied, confirming earlier No colony growth was observed with AML 9 and 14 even when the cell concentration was raised to 3 x 105/mL. Colony formation was observed, however, when cultures were performed at 10' cells/mL with 5637 CM added: 13 colonies (AML 14) and 70 colonies (AML 9). Furthermore, AML 9 cells responded to the synergistic effects of GM-CSF with either G-CSF, IL-la, or TNFa, whereas none of these growth factors alone was able to support colony formation. The results suggest that the GM-CSF receptor of patient sample 9 is functional ( Table 6 ).
The concentration of GM-CSF required for half-maximal stimulation of AML blast colony formation was relatively constant (5 to 36 pmol/L) ( Table 4 and Fig 6) . The shapes of the dose-response curves were similar for all AML blasts. Indeed, the EC,, of the proliferative response (5 to 36 pmol/L) was in the range of the kd of the high-affinity receptor (3 to 73 pmol/L) when statistical errors in the analyses of the saturation curves were taken into account. 
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The characteristics of the low-affinity receptor were estimated from analysis of saturation curves performed with GMCSF iodinated by the Bolton-Hunter reagent, covering radioligand concentrations from 5 to 2,500 pmol/L
DISCUSSION
Binding of labeled GM-CSF to specific receptors was documented for AML blasts from 14 patients surveyed in the present study. Because GM-CSF can support proliferation of normal and leukemic hematopoietic progenitors,'.' our results, together with those reported by several groups of investigators, suggest that GM-CSF receptor expression is a common characteristic shared by AML blasts and normal granulomonopoietic Because a relatively high percentage of AML samples can produce GM-CSF,l6.l7 it was important to determine whether the low level of binding observed in some patients' samples could be related to receptor occupancy. We therefore devised an acid wash procedure that could remove more than 80% of surface-bound GM-CSF without affecting receptor properties. Thus, we showed that the specific binding of GM-CSF to the cells was not modified by acid treatment. The low level of GM-CSF receptor expression by some AML samples is therefore not the result of receptor occupancy by an endogenous source of GM-CSF.
An important characteristic of GM-CSF receptor expression (shared with other hematopoietic growth factors such as G-CSF) is the small number of binding sites per cell. Indeed, earlier reports indicated that specific binding of GM-CSF was not detectable in some AML patient To circumvent this problem, we improved binding studies by adjusting the temperature of incubation and increasing cell numbers to lo7 per point when necessary. Thus, specific binding of 12'I-GM-CSF could be detected on all AML patient samples surveyed in the present study. In addition, we used a computer modeling method for data analysis that is more efficient than Scatchard analysis, especially when specific binding is weak. Furthermore, this method has two advantages: it provides confidence limits for each parameter estimated and also allows comparison of the goodness of fit between analyses using equations for single or multiple binding sites.
Binding studies suggested the presence of two classes of binding sites on AML blasts, in accordance with a recent report by Park et al." Although the number of high-affinity GM-CSF binding sites was shown for all patient samples, the kd was documented for only one sample and was 100 * 60 pmol/L. In the present study, we report a kd of less than 23 pmol/L for the high-affinity binding site, with the exception of three of our samples, AML 10, AML 12, and AML 13, for which we found a kd of 50 to 100 pmol/L. Coincidentally, samples AML 10 and 12 contained 12% and 5% monocytes, whereas binding of GM-CSF to AML 13 cells was relatively low, which may have caused higher uncertainties in the analysis. Budel et a1 recently reported some differences in the binding characteristics of GM-CSF receptors of normal PB cells as compared with AML blasts (higher kd and receptor number"'). Thus, interpretation of binding results in the presence of contaminating normal cells may be biased. Kelleher et a19 also identified the presence of a high-affinity receptor for GM-CSF, on AML blasts with, however, a wider range in kd (19 to 283 pmol/L) than that which we report. This difference might be attributed to the fact that two sources of GM-CSF were used, CHO-GM-CSF and COS-GM-CSF. Indeed, these two recombinant proteins appear to display differences in their hematopoietic proliferative effects and in their affinities for GM-CSF receptor on neutrophils. ' five cells were observed.
class of receptor: Hence, a higher kd resulted. Statistical analyses of our saturation curves were compatible with the presence of two classes of GM-CSF binding sites (P < .005).
The low-affinity binding site appears to be expressed at higher levels, with a kd in the range of 1 to 10 nmol/L, in accordance with previous observations by Park et al.', Cell-surface receptors with both high and low affinities were also reported for murine GM-CSF," IL-l,27 and IL-2.28-30 
